Today, the Hong Kong stock medical sector continues to rise. As of 9:36, Sihuan Pharmaceutical rose 7.32%, Xiansheng Pharmaceutical rose 7.18%, Kangji Medical rose 3.94%, Development Pharmaceutical-B rose 2.65%, and Xianjian Technology rose 2%.

Shanxi Securities said that the demographic adjustment brings rigid demand, the industry fundamentals are good; the current overall valuation of the plate is at a historically low level, the value of core assets appears; policies are intensive, and the normalization of volume procurement continues to accelerate industry differentiation.

Hang Seng Medical ETF (513060) fell slightly at the start of trading, then rebounded strongly, up 0.49% in intraday trading, recording San Lianyang. The share growth rate of the product has reached 122% in the past three months and 682% in the past six months, breaking through the 500 million yuan mark in one fell swoop and making steady progress towards 600 million yuan.